Release Date: January 26, 2021
Expiration Date: January 26, 2023
Estimated Time of Completion: 1 hour and 15 minutes
Description
Medical Dermatology Therapy Update online series will provide a review of traditional therapeutics,
as well as
biologic and small-molecule therapies, as it applies to a range of important medical dermatologic
conditions. In
addition it includes an overview of the pathogenesis and diagnosis of various medical dermatologic
diseases.
The Update in Medical Treatment of Cutaneous Malignancies webcast webcast will review the following medical conditions: melanoma and MF and Sezary Syndrome.
Learning Objectives
- Correlate clinical presentations of cutaneous T-cell lymphoma (CTCL) with T cell subtypes.
- Describe an appropriate treatment plan that is appropriate for Stage of disease.
- Use and interpret diagnostic tests for diagnosing and subtyping CTCL’s.
- Review changes in incidence and overall survival for melanoma with new systemic therapies of the last decade.
- Describe 2 major classes of systemic therapy for melanoma and mechanisms of action for each class.
- Discuss cutaneous toxicities as related to new systemic therapies in melanoma.
- Introduce upcoming developments in the systemic treatment of melanoma.
Target Audience
These activities are directed to physicians and advanced practice clinicians in
dermatology, immunology, oncology, rheumatology, internal medicine, and other health
care professionals caring for patients with autoimmune, chronic inflammatory, and
advanced malignant diseases.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing
medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring
material for a maximum of 1.25 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the
American Osteopathic Association for Category 2 credit.
ABIM MOC: Successful completion of this CME activity, which includes
participation in the evaluation component,
enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American
Board of Internal
Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn
MOC points equivalent to
the amount of CME credits claimed for the activity. It is the CME activity
provider's responsibility to submit
participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Activity Director and Faculty
Activity Director
Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH
Faculty
Kevin Cooper, MD
Professor, Dermatology and Pathology
Case Western Reserve University School of Medicine
Interim Division Chief, Dermatology
University Hospitals Rainbow Babies and Children’s Hospital
Chairman, Department of Dermatology
University Hospitals Cleveland Medical Center
Cleveland, OH
Pauline Funchain, MD
Department of Hematology and Medical Oncology
Cleveland Clinic Cancer Center
Cleveland Clinic
Cleveland, OH
CME Disclaimer
The information in this educational activity is provided for general medical education
purposes only and is not meant to substitute for the independent medical judgment of a
physician relative to diagnostic and treatment options of a specific patient's medical
condition. The viewpoints expressed in this CME activity are those of the
authors/faculty. They do not represent an endorsement by The Cleveland Clinic
Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision
made or action taken in reliance upon the information provided through this CME
activity.
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for
Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing
Education requires resolution of all faculty conflicts of interest to ensure CME activities are free
of commercial bias.
The following faculty have indicated that they may have a relationship which, in the context of their
presentation(s), could be perceived as a potential conflict of interest:
| Kevin Cooper, MD |
| |
Soligenix |
Research / Independent Contractor |
| Anthony P. Fernandez, MD, PhD |
| |
AbbVie Pharmaceuticals
|
Consulting
Membership on advisory committee or review panels
Teaching and Speaking
|
| |
Celgene Corporation
|
Consulting
|
| |
Corbus Pharmaceuticals
|
Research / Independent Contractor
|
| |
Mallinckrodt Inc.
|
Consulting
Research / Independent Contractor
Teaching and Speaking
|
| |
Novartis
|
Consulting
Research / Independent Contractor
Teaching and Speaking
|
| |
Pfizer, Inc.
|
Research / Independent Contractor
|
| |
Roche Pharmaceuticals
|
Principal Investigator for a Phase III Clinical Trial
|
| |
UCB
|
Consulting
|
| Pauline Funchain, MD |
| |
BMS, Pfizer |
Research / Independent Contractor |
Acknowledgment
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:
Amgen Inc.
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
This CME activity was produced by the Cleveland Clinic Foundation Center for
Continuing Education
and the Dermatology and Plastic Surgery Institute.
